Ajanta Pharma Limited
Canara Robeco Mutual Fund trimmed its stake in Ajanta Pharma from 1.48% to 1.46%, selling 21,080 shares.
A manufacturer of specialty pharmaceutical finished dosages, this company develops and markets formulations across therapeutic categories including ophthalmology, gastroenterology, and dermatology for domestic and international markets. With vertically integrated operations spanning development, manufacturing, and marketing, the company has established a significant presence in India's pharmaceutical sector through its robust distribution network and focus on quality production.
Joint venture between Canara Bank and Robeco of Netherlands. Manages over Rs 1.5 lakh crore. Canara Robeco Equity Hybrid Fund and Canara Robeco Emerging Equities are among its best-regarded offerings with long consistent track records. Backed by the Canara Bank network for distribution across Tier 2 and Tier 3 India.